{
    "url_original": "https://www.wsj.com/articles/fda-review-of-pfizer-covid-19-vaccine-in-children-under-5-expected-soon-11644580801?mod=politics_lead_pos10",
    "url": "fda-review-of-pfizer-covid-19-vaccine-in-children-under-5-expected-soon-11644580801",
    "title": "FDA Review of Pfizer Covid-19 Vaccine in Children Under 5 Expected Soon",
    "sub_head": "A decision by the agency on whether to authorize the shot is likely to come this month",
    "category_1": "Health",
    "time": "2022-02-11 07:00:00",
    "body": "U.S. health regulators are expected to release as soon as Friday their review of an application to expand access to the Covid-19 vaccine from  Pfizer Inc.  and  BioNTech SE  to children under 5 years old.<br />The children, including those as young as six months, are the last group of people waiting on access to shots."
}